What cybersecurity controls are needed for FDA 21 CFR Part 11 and HIPAA compliance?
FDA 21 CFR Part 11 and HIPAA compliance require cybersecurity controls that protect electronic records, protected health information (PHI), laboratory information management systems (LIMS), electronic laboratory notebooks (ELN), research repositories, scientific workflows, and regulated data.
Table of contents
How does SOC monitoring support FDA 21 CFR Part 11 readiness?
SOC monitoring supports FDA 21 CFR Part 11 readiness by providing visibility into security events, user activity, authentication records, and system changes that could affect the data integrity of regulated electronic records.
What is data integrity?
In regulated biotech environments, data integrity refers to maintaining the accuracy, completeness, consistency, and traceability of electronic records throughout their lifecycle
Monitoring activities frequently include LIMS platforms, ELN systems, laboratory workstations, and cloud-hosted research applications. Security operations teams commonly track:
- Privileged account activity
- Authentication failures
- Unauthorized access attempts
- Audit log events
- Configuration modifications
- Suspicious system behavior
Laboratory information management systems (LIMS), Electronic Laboratory Notebooks (ELN), research repositories, and cloud platforms frequently contain records subject to regulatory scrutiny. Managed security providers, such as Single Point of Contact, can help organizations maintain visibility across these environments while supporting operational oversight.
Continuous review of security events helps identify issues affecting auditability, data integrity, and electronic record protection before they escalate into larger compliance concerns.
What HIPAA cybersecurity controls should biotech companies prioritize?
Biotech companies should prioritize safeguards that protect PHI, prevent unauthorized access, and comply with HIPAA Security Rule requirements.
Core controls include:
- Multi-factor authentication
- Role-based access controls
- Data encryption
- Endpoint protection
- Vulnerability management
- Security awareness training
- Incident response procedures
- Backup and recovery capabilities
- Audit trail retention
- Privileged access management
The chart below summarizes common priorities.
Control area | Primary objective | Security benefit |
Authentication | Identity validation | Reduced account compromise |
Access management | Permission control | Least-privilege enforcement |
Encryption | Data protection | Reduced information exposure |
Endpoint security | Device protection | Improved threat resistance |
Incident response | Threat containment | Faster recovery |
Backup recovery | Operational continuity | Reduced disruption |
Organizations that focus on foundational protections create stronger defenses for sensitive information while supporting HIPAA-related obligations.
How do cybersecurity controls support data integrity in regulated biotech environments?
Cybersecurity controls support data integrity by helping ensure that regulated information remains accurate, complete, consistent, and traceable throughout its lifecycle. FDA 21 CFR Part 11 places significant emphasis on maintaining trustworthy electronic records and preventing unauthorized changes that could affect scientific, clinical, or operational outcomes.
Controls that support data integrity include:
- Role-based access controls
- Multi-factor authentication
- Audit trail monitoring
- Change management procedures
- Data encryption
- System activity logging
- Backup and recovery processes
These safeguards help protect laboratory information management systems (LIMS), electronic laboratory notebooks (ELN), research repositories, and other platforms that store regulated information. Strong data integrity practices help organizations maintain confidence in scientific records while supporting compliance objectives.
What cybersecurity documentation should a biotech maintain for HIPAA and FDA-related systems?
Biotech companies should maintain documentation that demonstrates governance, operational oversight, risk management, and security program execution.
Common records include:
- Risk assessments
- Security policies
- Access review reports
- Incident response procedures
- Audit log retention standards
- Vulnerability management records
- Security awareness training documentation
- Business continuity plans
- Change management records
- Audit trail retention procedures
Organizations working with managed security providers, such as Single Point of Contact, frequently supplement internal documentation with monitoring reports, investigation records, and operational summaries. Well-organized documentation helps streamline regulatory reviews, partner assessments, and compliance audits.
What systems should be included in compliance monitoring programs?
Compliance monitoring programs should include systems that store, process, transmit, or provide access to regulated information, electronic records, protected health information, or sensitive research data.
Common systems include:
- Laboratory information management systems (LIMS)
- Electronic laboratory notebooks (ELN)
- Research data repositories
- Clinical data platforms
- Identity and access management systems
- Cloud applications
- Microsoft 365 environments
- Laboratory workstations
- Backup and recovery platforms
- Security logging systems
- Manufacturing quality systems
- Clinical trial platforms
Many biotech environments rely on interconnected platforms that support scientific workflows, collaboration, and regulated operations. Comprehensive visibility across these systems helps organizations identify potential compliance issues earlier and maintain stronger operational oversight.
How can a SOC help with compliance reporting for biotech?
A SOC helps with compliance reporting by collecting security information, maintaining event visibility, supporting investigations, and producing operational records that demonstrate ongoing oversight.
Reporting activities commonly include:
- Security event summaries
- Alert investigation records
- Access review findings
- Incident documentation
- Log management reports
- Vulnerability remediation tracking
Compliance teams, auditors, investors, and business partners frequently request evidence that controls are functioning as intended. Providers, such as Single Point of Contact, may help generate reports that support governance efforts and simplify preparation for external reviews. Reliable reporting creates a stronger foundation for demonstrating accountability and operational discipline.
How do audit trails support FDA 21 CFR Part 11 and HIPAA compliance?
Audit trails support FDA 21 CFR Part 11 and HIPAA compliance by creating a record of system activity, user actions, and changes affecting regulated information. These records help organizations demonstrate accountability, investigate security events, and validate the integrity of electronic records.
Audit trails commonly capture:
- User logins and logouts
- Record creation activities
- Data modifications
- Permission changes
- Electronic signature events
- Administrative actions
- Security-related events
Effective audit trail management helps organizations understand who performed specific actions, when activities occurred, and what changes were made. Maintaining accurate records supports regulatory reviews, internal investigations, and compliance reporting efforts.
What cybersecurity evidence should a biotech have before an audit?
Biotech companies should maintain evidence showing that controls are implemented, reviewed, tested, and operating effectively over time.
Examples include:
- Risk assessment results
- Security monitoring records
- Access review documentation
- Incident response testing reports
- Audit log samples
- Remediation records
- Security training completion records
- Recovery testing results
- User access certification records
- Change control documentation
Reviewers frequently evaluate both the existence of controls and the evidence supporting their operation. Organizations that maintain documentation throughout the year are generally better prepared for audits than those attempting to gather information immediately before an assessment.
What additional safeguards support regulated biotech environments?
Regulated environments benefit from layered protections that support electronic records, scientific workflows, and sensitive information throughout the research lifecycle.
Additional safeguards include:
- Network segmentation
- Privileged access management
- Data loss prevention
- Cloud security monitoring
- Third-party risk management
- Configuration management
Many biotech organizations rely on interconnected laboratory systems, cloud services, and external collaborators. Layered safeguards help reduce exposure while supporting research productivity and operational efficiency.
How do risk assessments support compliance programs?
Risk assessments help organizations identify vulnerabilities, evaluate business impact, prioritize remediation efforts, and document a structured approach to risk management.
Assessment activities typically involve:
- Identifying regulated systems
- Evaluating technical safeguards
- Reviewing user permissions
- Assessing third-party exposure
- Analyzing security gaps
- Prioritizing corrective actions
Managed security providers, such as Single Point of Contact, may assist with gathering technical information that contributes to broader assessment activities. Regular evaluations help organizations align security investments with compliance requirements and operational objectives.
Maintaining cybersecurity readiness for FDA and HIPAA requirements
FDA 21 CFR Part 11 and HIPAA compliance require more than policies and procedures. Effective programs combine access management, monitoring, documentation, reporting, risk assessment, and operational oversight that support both security and regulatory expectations.
Organizations that maintain visibility into regulated environments, preserve evidence of security activities, and document ongoing governance efforts are better positioned to protect sensitive information, demonstrate accountability, and navigate audits with greater confidence.
Where can biotech companies learn more about managed security providers?
Organizations can learn how managed security services support biotech environments through Single Point of Contact’s biotech IT and security services. Services include 24×7 monitoring, threat detection, incident response, compliance support, Microsoft 365 security, and protection of research data and intellectual property.
Related Articles
What is the minimum viable cybersecurity program for an emerging biotech?
Early-stage biotech companies need practical security controls that protect research without overwhelming limited resources. Learn which foundational safeguards, monitoring capabilities, identity protections, backup strategies, and risk-management practices provide the strongest security value at startup scale.
Biotech managed security resource center
This hub provides an overview of biotech cybersecurity, including managed security services, MDR, managed SOC, security operations maturity, intellectual property protection, ransomware preparedness, compliance requirements, audit readiness, vendor risk management, and strategies for securing research environments.
Biotech cybersecurity services overview
This page provides an overview of cybersecurity, compliance, cloud, and managed IT services for biotech companies. Learn how life sciences organizations protect research data, support laboratory environments, strengthen operational resilience, meet regulatory requirements, and align technology strategies with scientific and business objectives.
Frequently asked questions
Text
About the author
Gregory Morawietz is a technology executive with experience evaluating and comparing IT and security service models. He helps organizations understand trade-offs among delivery models in terms of cost, scalability, and operational impact. His work includes supporting organizations in regulated industries such as life sciences, healthcare, and technology. Gregory brings a structured, practical perspective to the comparison of technologies and service models in a complex and evolving landscape.